SB
Sunita Barnwal
About Sunita Barnwal
Data last updated:
Sunita Barnwal is a Director at Astragenex Pharmaceuticals Private Limited (since 2020). The company operates in Chemicals. Astragenex Pharmaceuticals Private Limited reported revenue of ₹25.7 Lakh (FY 2022).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 11 Nov 2020 | 2020 | ₹25.7 Lakh (FY 2022) | Active |
Board colleagues of Sunita Barnwal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Poonam Verma | 08829008 | Astragenex Pharmaceuticals Private Limited | Director |
| Shambhu Nath Keshri | 08957481 | Astragenex Pharmaceuticals Private Limited | Director |
| Sweta Sinha | 08957493 | Astragenex Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sunita Barnwal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sunita Barnwal
Sunita Barnwal currently holds 1 directorship: Astragenex Pharmaceuticals Private Limited (Director, since 11 Nov 2020, revenue ₹25.7 Lakh (FY 2022)).
Sunita Barnwal was first appointed on 11 Nov 2020 as Director at Astragenex Pharmaceuticals Private Limited.
The current boards of Sunita Barnwal's companies include Poonam Verma (Astragenex Pharmaceuticals Private Limited), Shambhu Nath Keshri (Astragenex Pharmaceuticals Private Limited), Sweta Sinha (Astragenex Pharmaceuticals Private Limited).